Chronic Pain — 05 April 2013

fda-logo4By Pat Anson, Editor

The head of the Food and Drug Administration says her agency is considering a change in the labeling requirements for opioid painkillers – a move that many pain patients fear will make opioid analgesics harder to get.

In a speech this week at a national drug abuse summit and on her blog, FDA commissioner Margaret Hamburg called the abuse of prescription drugs “a public health crisis of enormous and devastating proportion” and said her agency would take a number of steps to prevent abuse, including “modifying opioid labeling.”

“We recognize that some are calling for further limitations on the use of these products, particularly in the context of non-cancer pain, including limiting the recommended duration of treatment; setting a maximum daily dosage limit; and restricting the use of these drugs to patients with severe pain,” Hamburg said.

“If additional improvements could make the labels more effective, it’s important we explore them as part of our overall efforts to improve the safety of opioids.”

Read more at National Pain Report.



About Author

Pat Anson, Editor

Pat is Editor in Chief of American News Report. He is a veteran journalist and a former correspondent and producer for HealthWeek (PBS), Nightly Business Report (PBS) and other nationally syndicated shows. Pat has won numerous journalism awards, including a Golden Mike award for investigative reporting.

(0) Readers Comments

Comments are closed.